Filing Details
- Accession Number:
- 0001001250-21-000038
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-04 14:00:23
- Reporting Period:
- 2021-03-02
- Accepted Time:
- 2021-03-04 14:00:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1001250 | Estee Lauder Companies Inc | EL | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
942617 | S Ronald Lauder | C/O The Estee Lauder Companies Inc. 767 Fifth Avenue New York NY 10153 | Chairman, Clinique Labs Llc | No | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Disposition | 2021-03-02 | 46,370 | $289.97 | 32,001 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2021-03-02 | 22,127 | $291.09 | 9,874 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2021-03-02 | 9,874 | $291.82 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Class A Common Stock | 6,364 | Indirect | by Descendants of RSL 1966 Trust |
Footnotes
- The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
- Sales prices range from $289.45 to $290.31 per share, inclusive.
- Sales prices range from $290.49 to $291.48 per share, inclusive.
- Sales prices range from $291.51 to $292.42 per share, inclusive.
- RSL disclaims beneficial ownership of these shares to the extent he does not have a pecuniary interest in such securities.